United States

Karyopharm Therapeutics Inc (KPTI.OQ)

KPTI.OQ on NASDAQ Stock Exchange Global Select Market

19 Jul 2018
Change (% chg)

$0.47 (+2.51%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Sharon Shacham

46 2013 President, Co-Founder, Chief Scientific Officer, Director

Michael Kauffman

53 Co-Founder, Chief Executive Officer and Director

Michael Falvey

58 2017 Chief Financial Officer, Executive Vice President, Treasurer, Principal Financial Officer, Principal Accounting Officer

Anand Varadan

50 2018 Executive Vice President, Chief Commercial Officer

Christopher Primiano

36 2015 Senior Vice President, General Counsel, Secretary